Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hodgkin's disease with bone marrow involvement.

R Gupta, P M Parikh, S H Advani

    Indian Journal of Cancer
    |June 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First-line management of metastatic non-small cell lung cancer: An Indian perspective.

    South Asian journal of cancer·2019
    Same author

    Practical consensus recommendations for tumor margins and breast conservative surgery.

    South Asian journal of cancer·2018
    Same author

    Practical consensus recommendations on fertility preservation in patients with breast cancer.

    South Asian journal of cancer·2018
    Same author

    Practical consensus recommendations for gestational breast cancer.

    South Asian journal of cancer·2018
    Same author

    Practical consensus recommendations regarding the management of sentinel lymph node issues in early breast cancer.

    South Asian journal of cancer·2018
    Same author

    Practical consensus recommendations regarding the management of HER2 neu positive metastatic breast cancer.

    South Asian journal of cancer·2018

    Bone marrow involvement in Hodgkin

    Area of Science:

    • Hematology
    • Oncology
    • Pathology

    Background:

    • Bone marrow involvement (BMI) is a critical prognostic factor in Hodgkin's Disease (HD).
    • Understanding the clinical and histopathological characteristics of BMI is essential for patient management.

    Purpose of the Study:

    • To analyze the clinicopathological features of bone marrow involvement in Hodgkin's Disease.
    • To evaluate the correlation of various parameters with disease activity and survival.

    Main Methods:

    • Retrospective analysis of 32 patients with confirmed bone marrow involvement in Hodgkin's Disease.
    • Evaluation of pre-treatment biopsy specimens using histopathological criteria.
    • Assessment of clinical staging, B-symptoms, organomegaly, ESR, alkaline phosphatase, serum copper, and hemoglobin levels.

    Related Experiment Videos

    Main Results:

    • Bone marrow involvement was observed in 11% of Hodgkin's Disease patients.
    • Male predominance and peak incidence in the fourth decade were noted.
    • Mixed cellularity and lymphocytic depletion subtypes showed higher BMI frequency.
    • Elevated ESR, alkaline phosphatase, serum copper, and anemia correlated with disease activity.
    • A 5-year overall survival rate of 31% was observed, with 18% disease-free survival.

    Conclusions:

    • Bone marrow involvement in Hodgkin's Disease is associated with specific demographic and histopathological features.
    • Biochemical markers and anemia are valuable indicators of disease activity.
    • The overall survival rate for patients with bone marrow involvement remains suboptimal, highlighting the need for improved therapeutic strategies.